BioLight Life Financials
| BOLT Stock | ILS 350.00 10.00 2.78% |
BioLight |
Understanding current and past BioLight Life Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioLight Life's financial statements are interrelated, with each one affecting the others. For example, an increase in BioLight Life's assets may result in an increase in income on the income statement.
The data published in BioLight Life's official financial statements usually reflect BioLight Life's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of BioLight Life Sciences. For example, before you start analyzing numbers published by BioLight accountants, it's critical to develop an understanding of what BioLight Life's liquidity, profitability, and earnings quality are in the context of the Life Sciences Tools & Services space in which it operates.
Please note, the presentation of BioLight Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BioLight Life's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in BioLight Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BioLight Life Sciences. Please utilize our Beneish M Score to check the likelihood of BioLight Life's management manipulating its earnings.
BioLight Life Stock Summary
BioLight Life competes with Bezeq Israeli, and Compugen. BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions comprising glaucoma, dry eye syndrome, and age-related macular degeneration. BioLight Life Sciences Ltd. was founded in 2005 and is based in Tel Aviv, Israel. BIOLIGHT LIFE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.| Foreign Associate | USA |
| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| ISIN | IL0010952237 |
| Business Address | Atidim Park Tel |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | bio-light.co.il |
| Phone | 972 7 327 53400 |
| Currency | ILS - Israeli Shekel |
You should never invest in BioLight Life without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of BioLight Stock, because this is throwing your money away. Analyzing the key information contained in BioLight Life's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
BioLight Life Key Financial Ratios
Generally speaking, BioLight Life's financial ratios allow both analysts and investors to convert raw data from BioLight Life's financial statements into concise, actionable information that can be used to evaluate the performance of BioLight Life over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BioLight Life Sciences reports annually and quarterly.| Return On Equity | -0.0911 | |||
| Return On Asset | -0.0925 | |||
| Target Price | 12.0 |
BioLight Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioLight Life's current stock value. Our valuation model uses many indicators to compare BioLight Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioLight Life competition to find correlations between indicators driving BioLight Life's intrinsic value. More Info.BioLight Life Sciences is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioLight Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioLight Life's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioLight Life's earnings, one of the primary drivers of an investment's value.BioLight Life Sciences Systematic Risk
BioLight Life's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BioLight Life volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on BioLight Life Sciences correlated with the market. If Beta is less than 0 BioLight Life generally moves in the opposite direction as compared to the market. If BioLight Life Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioLight Life Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioLight Life is generally in the same direction as the market. If Beta > 1 BioLight Life moves generally in the same direction as, but more than the movement of the benchmark.
About BioLight Life Financials
What exactly are BioLight Life Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include BioLight Life's income statement, its balance sheet, and the statement of cash flows. Potential BioLight Life investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although BioLight Life investors may use each financial statement separately, they are all related. The changes in BioLight Life's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BioLight Life's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze BioLight Life Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as BioLight Life is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of BioLight has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if BioLight Life's financials are consistent with your investment objective using the following steps:- Review BioLight Life's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand BioLight Life's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare BioLight Life's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if BioLight Life's stock is overvalued or undervalued.
BioLight Life April 19, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BioLight Life help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioLight Life Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioLight Life Sciences based on widely used predictive technical indicators. In general, we focus on analyzing BioLight Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioLight Life's daily price indicators and compare them against related drivers.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 18.31 | |||
| Value At Risk | (5.57) | |||
| Potential Upside | 5.69 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLight Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for BioLight Stock analysis
When running BioLight Life's price analysis, check to measure BioLight Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLight Life is operating at the current time. Most of BioLight Life's value examination focuses on studying past and present price action to predict the probability of BioLight Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLight Life's price. Additionally, you may evaluate how the addition of BioLight Life to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |